We are live on
!
Find out more
PC
Pier Capital Portfolio holdings
AUM
$755M
1-Year Est. Return
94.38%
This Fund
S&P 500
This Quarter
Est. Return
-4.57%
1 Year Est. Return
+94.38%
3 Year Est. Return
+222.94%
5 Year Est. Return
+261.19%
10 Year Est. Return
+2,769.67%
AUM
$614M
AUM Growth
-$80.1M
(-12%)
Cap. Flow
-$30.1M
Cap. Flow
% of AUM
-4.9%
Top 10 Holdings %
Top 10 Hldgs %
13.3%
Holding
146
New
29
Increased
54
Reduced
35
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AtriCure
ATRC
|
+$7.41M |
| 2 |
DVAX
Dynavax Technologies
DVAX
|
+$7.06M |
| 3 |
HDP
Hortonworks, Inc.
HDP
|
+$7.01M |
| 4 |
EXL Service
EXLS
|
+$6.89M |
| 5 |
Strategy Inc
MSTR
|
+$6.82M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 Growth ETF
IWO
|
+$8.99M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$8.22M |
| 3 |
SBNY
Signature Bank
SBNY
|
+$7.76M |
| 4 |
Jack in the Box
JACK
|
+$7.43M |
| 5 |
Caesarstone
CSTE
|
+$7.21M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.4% |
| 2 | Healthcare | 16.87% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Industrials | 12.8% |
| 5 | Financials | 5.62% |
Similar funds
HCM
FSCM
RMC
BEC
MWA
TPW
OM
MGM
Pier Capital's Q3 2015 Portfolio in Review
As of Q3 2015, Pier Capital held 146 positions worth $614M, down 12% from $694M the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Pier Capital withdrew a net $30.1M in Q3 2015, closing 28 positions and reducing 35 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $8.22M position sold in full.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Pier Capital opened a new position in AtriCure worth $6.5M.
- Pier Capital's largest Q3 2015 buy was AtriCure: 296,688 shares worth $6.5M.
- Pier Capital added most to The Brand House Collective in Q3 2015, an estimated $4.06M increase.
- Pier Capital's biggest Q3 2015 reduction was iShares Russell 2000 Growth ETF, cutting an estimated $8.99M.
- Pier Capital fully exited Intra-Cellular Therapies Inc. in Q3 2015, selling an estimated $8.22M.
- Pier Capital's ten largest holdings make up 13% of its $614M portfolio in Q3 2015.
- Pier Capital opened 29 new positions and closed 28 in Q3 2015.
- Pier Capital's portfolio value fell 12% quarter-over-quarter to $614M.
Based on Pier Capital's 13F filing for Q3 2015, filed 10 Nov 2015.